Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
Arribillaga L, de Cerio AL, Sarobe P, Casares N, Gorraiz M, Vales A, Bruna-Romero O, Borrás-Cuesta F, Paranhos-Baccala G, Prieto J, Ruiz J, Lasarte JJ. Arribillaga L, et al. Among authors: de cerio al. Vaccine. 2002 Dec 13;21(3-4):202-10. doi: 10.1016/s0264-410x(02)00456-5. Vaccine. 2002. PMID: 12450695 Free article.
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Casales E, Martisova E, Villanueva H, de Cerio ALD, Inoges S, Silva-Pilipich N, Ballesteros-Briones MC, Aranda A, Bezunartea J, Bendandi M, Pastor F, Smerdou C. Casales E, et al. Among authors: de cerio ald. Sci Rep. 2021 Nov 2;11(1):21427. doi: 10.1038/s41598-021-00787-5. Sci Rep. 2021. PMID: 34728659 Free PMC article.
Future of idiotypic vaccination for B-cell lymphoma.
de Cerio AL, Inogés S. de Cerio AL, et al. Expert Rev Vaccines. 2009 Jan;8(1):43-50. doi: 10.1586/14760584.8.1.43. Expert Rev Vaccines. 2009. PMID: 19093772 Free article. Review.
Idiotype vaccine production using hybridoma technology.
Inoges S, de Cerio AL, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: de cerio al. Methods Mol Biol. 2014;1139:367-87. doi: 10.1007/978-1-4939-0345-0_30. Methods Mol Biol. 2014. PMID: 24619694
Idiotype vaccines for human B-cell malignancies.
Inoges S, de Cerio AL, Soria E, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: de cerio al. Curr Pharm Des. 2010 Jan;16(3):300-7. doi: 10.2174/138161210790170111. Curr Pharm Des. 2010. PMID: 20109139 Free article. Review.
CD28 aptamers as powerful immune response modulators.
Pastor F, Soldevilla MM, Villanueva H, Kolonias D, Inoges S, de Cerio AL, Kandzia R, Klimyuk V, Gleba Y, Gilboa E, Bendandi M. Pastor F, et al. Among authors: de cerio al. Mol Ther Nucleic Acids. 2013 Jun 11;2(6):e98. doi: 10.1038/mtna.2013.26. Mol Ther Nucleic Acids. 2013. PMID: 23756353 Free PMC article.
Anti-idiotype antibodies in cancer treatment.
de Cerio AL, Zabalegui N, Rodríguez-Calvillo M, Inogés S, Bendandi M. de Cerio AL, et al. Oncogene. 2007 May 28;26(25):3594-602. doi: 10.1038/sj.onc.1210371. Oncogene. 2007. PMID: 17530013 Free article. Review.
20 results